Mexico's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.1 Bn in 2022 to $2.08 Bn by 2030, registering a CAGR of 45.47% during the forecast period of 2022-2030. The market will be driven by the increase in demand for improved healthcare services and government initiatives in improving healthcare infrastructure. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, PROSPERiA & WelbeCare.
The Mexico Artificial Intelligence (AI) in Healthcare Market is projected to grow from $0.1 Bn in 2022 to $2.08 Bn by 2030, registering a CAGR of 45.47% during the forecast period of 2022 - 2030. Mexico's budget for 2022 included a 14.6% rise in healthcare sector resources, primarily to address Covid-19, but it additionally prioritizes first and second-level care for high-speciality diseases like diabetes, cancer, and heart disease. Public healthcare organisations provide 70-80 % of the total of all health services nationwide, while private health organizations serve 25-30% of the Mexican population. Mexico recorded 704,358 more deaths than expected between 2020 and 2021, with COVID-19 being the leading cause, followed by heart disease and diabetes.
Adoption and utilization of artificial intelligence (AI) in healthcare in Mexico is still in its beginning phases, but it is rapidly expanding into a variety of applications such as telemedicine, which has been rapidly adopted in Mexico, particularly during the COVID-19 pandemic. In Mexico, many hospitals are implementing Hospital Information Systems (HIS) that use AI algorithms to aid in medical decisions, allocation of resources, and predictive modeling. AI-powered medical imaging technologies, such as computer-aided diagnosis (CAD) systems, are increasingly being used in Mexico to aid in disease detection and diagnosis. Moreover, various Mexico-based startups such as PROSPERiA, Unima, Mural Med & AGEMED have been utilizing AI solutions to leverage healthcare services.
Market Growth Drivers
Mexico is experiencing an increase in demand for improved healthcare services, especially among rural residents. Mexico generates a lot of healthcare data, such as electronic health records, medical images, and genomics data. AI can assist in the processing of this data and provide insights to enhance decision-making. The Mexican government has expressed a strong desire to promote the use of AI in healthcare. Several attempts have been made, including investments in R&D and the creation of a regulatory framework. AI advancements such as natural language processing, computer vision, and machine learning are allowing for the creation of more advanced healthcare applications.
Market Restraints
Mexico continues to face healthcare infrastructure challenges, particularly in rural areas, such as a lack of internet connectivity and outdated IT infrastructure. The use of AI in healthcare necessitates access to sensitive patient data, which raises privacy and security concerns. Implementing AI applications in healthcare can necessitate significant resources, both human and monetary. Smaller healthcare providers may have difficulty investing in AI technologies.
Key Players
July 2022, Cardo Health is collaborating with Prosperia, an MIT Media Lab social impact spinoff, to bring digital healthcare to Mexico. Prosperia has developed an integrated AI-based solution to massify diabetes detection and treatment and is now looking to expand its services, offering high-quality digital healthcare to Mexico's 130 million residents.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The Artificial Intelligence (AI) in Healthcare Market is segmented as mentioned below:
By Healthcare Component (Revenue, USD Billion):
By Healthcare Applications (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.